of the left ventricle if they had been randomly assigned the angiotensin receptor-neprilysin inhibitor (ARNI) treatment for 24 weeks instead of placebo (7.1% vs 25%, OR 0.23, 95% CI 0.07-0.75 ...
Dr Ileana Piña discusses facilitating RAAS inhibitors with potassium binders ... Is There a Role for the ARNI in HFpEF? Ileana Piña quizzes investigator Burkert Pieske on the findings for ...